CareTalk: Healthcare. Unfiltered.

Send us Fan MailFounder and former CEO of Avalere Health, Dan Mendelson, stops by to share his outlook on Bidencare and the future of health policy in the US. About Dan Mendelson:Dan Mendelson is Founder and former CEO of Avalere Health, a vibrant community of innovative thinkers dedicated to solving the challenges of the healthcare system.He is also Operating Partner at Welsh Carson, a private equity firm focused on healthcare and technology investments.  Prior to founding Avalere in 2000, Dan served as Associate Director for Health at the Office of Management and Budget in the Clinton White House where he was responsible for the full healthcare portfolio including Medicare, Medicaid, NIH, CDC, and FDA.  Dan presently serves on the boards of Champions Oncology (CSBR), Centrexion Corporation, and Audacious Inquiry.  He is Adjunct Professor at Georgetown University’s McDonough School of Business, and a founding member of Guidon Partners, an investment management group.  Dan also serves on advisory boards for the Alliance for Health Policy, the Duke Margolis Center, and Faster Cures.  He previously served on the boards of Coventry Healthcare (CVTY, sold to Aetna in 2013), PharMerica (PMC, sold to KKR in 2017), and HMS holdings (HMSY).Dan is a leading national thought leader on healthcare business issues, is often quoted in the press, and enjoys speaking.  He has also published widely in peer-reviewed and professional journals on health information technology, the costs of disease, hospital costs and operations, physician payment, the economics of managed care, and medical malpractice. He holds a BA from Oberlin College, and an MPP from the Kennedy School at Harvard University.Watch this episode on YouTube: https://youtu.be/QWKdKhwAICw#danmendelson​ #medicare​​ #medicareadvantage​​ #healthinsurance​​ #healthcare​​ #healthcarebusiness​​ #healthcarepolicySupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailCivil rights groups are calling for greater equity in vaccine distribution. But what are theyasking for exactly? In this episode, John and David discuss equity vs. efficiency in the vaccine rollout and whether or not there is a tradeoff. Watch this episode on YouTube: https://youtu.be/SKAzqpfphKQ#healthinsurance​ #healthcare​ #healthcarebusiness​ #healthcarepolicy #vaccineupdateSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailFormer US Representative, Allyson Schwartz, joins the show to discuss what makes Medicare Advantage a better option than traditional Medicare. Subscribe to CareTalk on your favorite podcast service:Spotify https://open.spotify.com/show/2GTYhbN...​...Apple Podcasts https://podcasts.apple.com/us/podcast...​...Google Podcasts https://podcasts.google.com/feed/aHR0...​...#allysonschwartz​ #medicare​ #medicareadvantage​ #healthinsurance​ #healthcare​ #healthcarebusiness​ #healthcarepolicySupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailNew York Times writer, Nick Kristof, recently published an article that asks whether or not Joe Biden is capable of saving Americans from the perils of poverty, drugs, mental-illness and more. In this episode of CareTalk, John and David debate what Kristof got right/wrong in his arguments.Read Nick Kristof's original NYT article, "Can Biden Save Americans Like My Old Pal Mike?" here: https://www.nytimes.com/2021/02/13/opinion/sunday/working-class-dignity.htmlWatch this episode on YouTube: https://youtu.be/hoYefzo9Qag#NickKristof #JoeBiden #Opinion #Healthcare #HealthcareBusiness #HealthcarePolicy #NewYorkTimes #TheNewYorkTimes #Health #Poverty #MentalIllnessSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailWhy is it taking so long for so many us to get vaccinated? What are the data and tracking problems hampering the CDC? Which states are taking better approaches than others? John and David have all the answers. Well...sort of.Watch this episode on YouTube: https://youtu.be/SdZwjDOZDZ0#healthcare​ #vaccine​ #CDC​ #healthcarepolicySupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailIn this episode of CareTalk, John and David break down President Biden's key executive orders and discuss how they will impact healthcare in the USA. Subscribe to CareTalk on your favorite podcast service:Spotify https://open.spotify.com/show/2GTYhbN​​...Apple Podcasts https://podcasts.apple.com/us/podcast​​...Google Podcasts https://podcasts.google.com/feed/aHR0​​...Watch this episode on YouTube: https://youtu.be/gOs6ymg45wc#healthcare​ #executiveorders​ #presidentbiden​ #healthcarepolicySupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailDr. Peter Bach (Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center) stops by the show to discuss the dangerous rise in cancer drug prices and how the Biden administration could tackle them. Watch this episode on YouTube: https://youtu.be/6h_rJmxe-eoAbout Dr. Peter Bach: Dr. Bach is the Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes, is a physician, epidemiologist, researcher, and respected healthcare policy expert whose work focuses on the cost and value of anticancer drugs. Dr. Bach is leading efforts to increase understanding of the US drug development process and develop new models for drug pricing that include value to patients. Dr. Bach described a 100-fold increase in cancer drug prices since 1965 after adjusting for inflation, and that the cost of an additional year of life from a cancer treatment increases by $8,500 each year. In 2012, he and other physicians at MSK drew attention to the high price of a newly approved cancer drug and announced his hospital’s unprecedented move not to offer it to patients because of its high price tag with no notable improved clinical outcomes. The drug price was later cut in half by the manufacturer. Dr. Bach’s work in lung cancer screening has led to the development of several lung cancer screening guidelines and one of the first-ever risk-prediction models for this disease. He has also proposed a number of strategies for Medicare to link payment to the value of healthcare services delivered.Dr. Bach has been inducted into the National Academy of Medicine, American Society of Clinical Investigators and the Johns Hopkins University Society of Scholars. He served as a Senior Advisor for Cancer Policy at the Center for Medicare and Medicaid Services in 2005 and 2006. He has published more than 100 peer-reviewed articles and editorials in scientific journals such as the N Engl J Med and the Journal of the American Medical Association. He has also written numerous healthcare-related op-eds and been featured in mainstream media outlets such as the New York Times, New York magazine, the Wall Street Journal, Forbes, NPR, and 60 Minutes. Dr. Bach completed his undergraduate studies at Harvard University and his medical studies at the University of Minnesota and the University of Chicago Harris School. He completed a residency in internal medicine at Johns Hopkins University followed by a fellowship in pulmonary and critical care medicine at the University of Chicago and Johns Hopkins. While at the University of Chicago, he was a Robert Wood Johnson Foundation Clinical Scholar. Dr. Bach has been a faculty member in MSK’s Department of Epidemiology and Biostatistics since 1998 and a Senior Scholar at the International Agency for Research on Cancer since 2008.#cancermedication #sloanketteringmemorialcancercenter #healthcare #drpeterbach #caretalkSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailPresident-elect Joe Biden has revealed his American Rescue Plan. In this episode, John and David take a deep dive into Biden's plan, while weighing the potential impact its policies can have on the United States as a whole. Watch this episode on YouTube: https://youtu.be/Y-UIxQpty-ESupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailDr. Shoshana Ungerleider (Founder, End Well Foundation) joins CareTalk to discuss how we can make end of life care a more humane experience. Watch this episode on YouTube: https://youtu.be/qMvg2rP_CYkAbout Dr. Shoshana Ungerleider: Dr. Shoshana Ungerleider is a physician, founder, speaker, producer and writer. She works as an internist practicing medicine at Crossover Health in San Francisco. She received her medical degree from Oregon Health & Science University in Portland, OR and completed residency at California Pacific Medical Center where she is now on the teaching faculty and serves on the Executive Board of the Foundation Board of Trustees. She is an LP in Trucks Venture Capital Fund.In 2017, Shoshana founded the End Well Foundation. End Well is an annual interdisciplinary convening and media platform focused on transforming the end of life into a human-centered experience. ​Shoshana was involved with two Academy Award-nominated Netflix short documentaries about the end of life experience: Extremis and End Game. Her most recent project is a biographical documentary film about the life of Robin Williams, Robin's Wish. Click here to learn more about the films she's worked with. ​Support the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailThe Pfizer and Moderna vaccines are officially approved by the FDA. But the vaccination program isn't going as planned. In this episode, hosts John Driscoll (CEO, CareCentrix) and David Williams (President, Health Business Group), cover everything that is going wrong with vaccinations in the USA. Watch this episode on YouTube: https://youtu.be/MJgGiOsddqASupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.